New perspectives in cyclic AMP-mediated axon growth and guidance: the emerging epoch of Epac

Andrew G. Peace, Derryck A. Shewan

Research output: Contribution to journalSpecial issue

26 Citations (Scopus)

Abstract

In the search for a cure to brain and spinal cord injury much has been learned about the inhibitory environment of the central nervous system (CNS), and yet a clinical therapy remains elusive. In recent years great advances have been made in understanding intracellular molecular mechanisms that transduce cell surface receptor-mediated signals that neurons receive from their environment. Many of these signalling pathways share common mechanisms, which presents the possibility that manipulating activities of key cell signalling molecules such as those regulated by 3'-5'-cyclic adenosine monophosphate (cAMP) might allow axons to simultaneously overcome the inhibitory effects of a number of extracellular ligands. The identification of Epac, a novel direct intracellular target for cAMP, has opened up a new avenue of research that is beginning to explain how cAMP can mediate a range of neuronal functions including distinct axon growth and guidance decisions. With current research tools that allow more specific activation of proteins or knock-down of their expression, as well as quantitation of protein activities in live cells, it is already becoming clear that Epac plays highly important roles in the development and function of the nervous system. Here, we focus on emerging evidence that Epac mediates cAMP-regulated axon growth and chemoattraction, and thus represents a novel target for overcoming axon growth inhibition and promoting CNS regeneration.
Original languageEnglish
Pages (from-to)280-288
Number of pages9
JournalBrain Research Bulletin
Volume84
Issue number4-5
DOIs
Publication statusPublished - 10 Mar 2010

Fingerprint

Cyclic AMP
Axons
Growth
Central Nervous System
Cell Surface Receptors
Spinal Cord Injuries
Research
Nervous System
Regeneration
Proteins
Ligands
Neurons
Axon Guidance
Brain
Therapeutics

Keywords

  • Epac
  • cAMP
  • PKA
  • CNS
  • growth cone
  • axon guidance
  • axon regeneration
  • DRG
  • cell signalling
  • FRET

Cite this

New perspectives in cyclic AMP-mediated axon growth and guidance : the emerging epoch of Epac. / Peace, Andrew G.; Shewan, Derryck A.

In: Brain Research Bulletin, Vol. 84, No. 4-5, 10.03.2010, p. 280-288.

Research output: Contribution to journalSpecial issue

@article{8530e62fc72c478fae681e05c48ab06b,
title = "New perspectives in cyclic AMP-mediated axon growth and guidance: the emerging epoch of Epac",
abstract = "In the search for a cure to brain and spinal cord injury much has been learned about the inhibitory environment of the central nervous system (CNS), and yet a clinical therapy remains elusive. In recent years great advances have been made in understanding intracellular molecular mechanisms that transduce cell surface receptor-mediated signals that neurons receive from their environment. Many of these signalling pathways share common mechanisms, which presents the possibility that manipulating activities of key cell signalling molecules such as those regulated by 3'-5'-cyclic adenosine monophosphate (cAMP) might allow axons to simultaneously overcome the inhibitory effects of a number of extracellular ligands. The identification of Epac, a novel direct intracellular target for cAMP, has opened up a new avenue of research that is beginning to explain how cAMP can mediate a range of neuronal functions including distinct axon growth and guidance decisions. With current research tools that allow more specific activation of proteins or knock-down of their expression, as well as quantitation of protein activities in live cells, it is already becoming clear that Epac plays highly important roles in the development and function of the nervous system. Here, we focus on emerging evidence that Epac mediates cAMP-regulated axon growth and chemoattraction, and thus represents a novel target for overcoming axon growth inhibition and promoting CNS regeneration.",
keywords = "Epac, cAMP, PKA, CNS, growth cone, axon guidance, axon regeneration, DRG, cell signalling, FRET",
author = "Peace, {Andrew G.} and Shewan, {Derryck A.}",
year = "2010",
month = "3",
day = "10",
doi = "10.1016/j.brainresbull.2010.09.002",
language = "English",
volume = "84",
pages = "280--288",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "4-5",

}

TY - JOUR

T1 - New perspectives in cyclic AMP-mediated axon growth and guidance

T2 - the emerging epoch of Epac

AU - Peace, Andrew G.

AU - Shewan, Derryck A.

PY - 2010/3/10

Y1 - 2010/3/10

N2 - In the search for a cure to brain and spinal cord injury much has been learned about the inhibitory environment of the central nervous system (CNS), and yet a clinical therapy remains elusive. In recent years great advances have been made in understanding intracellular molecular mechanisms that transduce cell surface receptor-mediated signals that neurons receive from their environment. Many of these signalling pathways share common mechanisms, which presents the possibility that manipulating activities of key cell signalling molecules such as those regulated by 3'-5'-cyclic adenosine monophosphate (cAMP) might allow axons to simultaneously overcome the inhibitory effects of a number of extracellular ligands. The identification of Epac, a novel direct intracellular target for cAMP, has opened up a new avenue of research that is beginning to explain how cAMP can mediate a range of neuronal functions including distinct axon growth and guidance decisions. With current research tools that allow more specific activation of proteins or knock-down of their expression, as well as quantitation of protein activities in live cells, it is already becoming clear that Epac plays highly important roles in the development and function of the nervous system. Here, we focus on emerging evidence that Epac mediates cAMP-regulated axon growth and chemoattraction, and thus represents a novel target for overcoming axon growth inhibition and promoting CNS regeneration.

AB - In the search for a cure to brain and spinal cord injury much has been learned about the inhibitory environment of the central nervous system (CNS), and yet a clinical therapy remains elusive. In recent years great advances have been made in understanding intracellular molecular mechanisms that transduce cell surface receptor-mediated signals that neurons receive from their environment. Many of these signalling pathways share common mechanisms, which presents the possibility that manipulating activities of key cell signalling molecules such as those regulated by 3'-5'-cyclic adenosine monophosphate (cAMP) might allow axons to simultaneously overcome the inhibitory effects of a number of extracellular ligands. The identification of Epac, a novel direct intracellular target for cAMP, has opened up a new avenue of research that is beginning to explain how cAMP can mediate a range of neuronal functions including distinct axon growth and guidance decisions. With current research tools that allow more specific activation of proteins or knock-down of their expression, as well as quantitation of protein activities in live cells, it is already becoming clear that Epac plays highly important roles in the development and function of the nervous system. Here, we focus on emerging evidence that Epac mediates cAMP-regulated axon growth and chemoattraction, and thus represents a novel target for overcoming axon growth inhibition and promoting CNS regeneration.

KW - Epac

KW - cAMP

KW - PKA

KW - CNS

KW - growth cone

KW - axon guidance

KW - axon regeneration

KW - DRG

KW - cell signalling

KW - FRET

U2 - 10.1016/j.brainresbull.2010.09.002

DO - 10.1016/j.brainresbull.2010.09.002

M3 - Special issue

VL - 84

SP - 280

EP - 288

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 4-5

ER -